These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A three-step tandem process for the synthesis of bicyclic gamma-lactams. McGonagle FI; Brown L; Cooke A; Sutherland A Org Biomol Chem; 2010 Aug; 8(15):3418-25. PubMed ID: 20508895 [TBL] [Abstract][Full Text] [Related]
27. Organometallic enantiomeric scaffolding: general access to 2-substituted oxa- and azabicyclo[3.2.1]octenes via a Brønsted acid catalyzed [5 + 2] cycloaddition reaction. Garnier EC; Liebeskind LS J Am Chem Soc; 2008 Jun; 130(23):7449-58. PubMed ID: 18479131 [TBL] [Abstract][Full Text] [Related]
28. Chirospecific synthesis of spirocyclic beta-lactams and their characterization as potent type II beta-turn inducing peptide mimetics. Bittermann H; Gmeiner P J Org Chem; 2006 Jan; 71(1):97-102. PubMed ID: 16388623 [TBL] [Abstract][Full Text] [Related]
29. New oxazole-based peptidomimetics: useful building blocks for the synthesis of orthogonally protected macrocyclic scaffolds. Mann E; Kessler H Org Lett; 2003 Nov; 5(24):4567-70. PubMed ID: 14627385 [TBL] [Abstract][Full Text] [Related]
30. Azabicycloalkenes as synthetic intermediates: application to the preparation of diazabicycloalkane scaffolds. Prenzel AH; Deppermann N; Maison W Org Lett; 2006 Apr; 8(8):1681-4. PubMed ID: 16597140 [TBL] [Abstract][Full Text] [Related]
31. Aza-Prins-pinacol approach to 7-azabicyclo[2.2.1]heptanes: syntheses of (+/-)-epibatidine and (+/-)-epiboxidine. Armstrong A; Bhonoah Y; Shanahan SE J Org Chem; 2007 Oct; 72(21):8019-24. PubMed ID: 17867705 [TBL] [Abstract][Full Text] [Related]
32. Utilizing the intramolecular Fukuyama-Mitsunobu reaction for a flexible synthesis of novel heterocyclic scaffolds for peptidomimetic drug design. Zapf CW; Del Valle JR; Goodman M Bioorg Med Chem Lett; 2005 Sep; 15(18):4033-6. PubMed ID: 16002286 [TBL] [Abstract][Full Text] [Related]
33. 7-substituted 2-azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn-and anti-isoepiboxidine. Malpass JR; White R J Org Chem; 2004 Aug; 69(16):5328-34. PubMed ID: 15287778 [TBL] [Abstract][Full Text] [Related]
35. Synthetic studies towards garsubellin A: synthesis of model systems and potential mimics by regioselective lithiation of bicyclo[3.3.1]nonane-2,4,9-trione derivatives from catechinic acid. Ahmad NM; Rodeschini V; Simpkins NS; Ward SE; Wilson C Org Biomol Chem; 2007 Jun; 5(12):1924-34. PubMed ID: 17551642 [TBL] [Abstract][Full Text] [Related]
37. Enantiospecific synthesis of annulated nicotine analogues from D-glutamic acid. 7-Azabicyclo[2.2.1]heptano[2.3-c]pyridines. Lennox JR; Turner SC; Rapoport H J Org Chem; 2001 Oct; 66(21):7078-83. PubMed ID: 11597233 [TBL] [Abstract][Full Text] [Related]
38. Preparation and Use of a General Solid-Phase Intermediate to Biomimetic Scaffolds and Peptide Condensations. Samaritoni JG; Martynow JG; O'Donnell MJ; Scott WL Molecules; 2018 Jul; 23(7):. PubMed ID: 30021979 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of azabicyclo[2.2.n]alkane systems as analogues of 3-[1-methyl-2-(S)-pyrrolidinyl- methoxy]pyridine (A-84543). Carreras J; Avenoza A; Busto JH; Peregrina JM J Org Chem; 2007 Apr; 72(8):3112-5. PubMed ID: 17371077 [TBL] [Abstract][Full Text] [Related]
40. Peptide scanning for studying structure-activity relationships in drug discovery. Jamieson AG; Boutard N; Sabatino D; Lubell WD Chem Biol Drug Des; 2013 Jan; 81(1):148-65. PubMed ID: 23253136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]